SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹97 Cr | ₹43 Cr | ₹26 Cr | ₹41 Cr | ₹39 Cr |
What is the latest Total Current Liabilities ratio of SYSCHEM (INDIA) ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹97 Cr |
Mar2023 | ₹43 Cr |
Mar2022 | ₹26 Cr |
Mar2021 | ₹41 Cr |
Mar2020 | ₹39 Cr |
How is Total Current Liabilities of SYSCHEM (INDIA) Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹97 Cr | 125.18 | |
Mar2023 | ₹43 Cr | 68.27 | |
Mar2022 | ₹26 Cr | -37.54 | |
Mar2021 | ₹41 Cr | 5.83 | |
Mar2020 | ₹39 Cr | - |
Compare Total Current Liabilities of peers of SYSCHEM (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYSCHEM (INDIA) | ₹201.8 Cr | 0.2% | -0.6% | 2.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,584.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,147.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹120,941.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,325.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,138.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
SYSCHEM (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYSCHEM (INDIA) | 0.2% |
-0.6% |
2.1% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses